Connect your AI

Globus Medical GMED Thereafter

Other financials

Income statement

Revenue$759.9M+27.0%

Gross profit$525.8M+30.6%

Operating income$150.4M+55.0%

Net income$124.3M+64.7%

EPS (diluted)$0.90+66.7%

Balance sheet

Cash & equivalents$561.0M+21.6%

Total debt$116.3M+25.0%

Total equity$4.7B+15.8%

Total assets$5.4B+15.5%

Cash flow

Operating cash flow$202.4M+14.1%

CapEx$39.6M+9.7%

Free cash flow$162.7M+15.3%

Valuation

Market cap$10.76B+15.7%

Enterprise value$10.31B+15.6%

P/E18.3×-31.7×

P/S3.5×-0.2×

Profitability

Gross margin67.9%+7.3pp

Operating margin17.2%+7.0pp

Net margin18.9%+11.5pp

FCF margin19.7%-1.1pp

Returns & leverage

Return on equity13.3%+8.7pp

Debt / equity0×0.0×

Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept gmed:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearThree.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's thereafter.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Globus Medical's thereafter?: Globus Medical (GMED) reported thereafter of $290.56M in Q1 2026.